Progyny, Inc. provided earnings guidance for the Second Quarter and Full Year 2024. For the Quarter, Revenue is projected to be $300.0 million to $310.0 million, reflecting growth of 7% to 11%, Net income is projected to be $15.7 million to $17.8 million, or $0.16 to $0.18 per diluted share, on the basis of approximately 99 million assumed weighted-average fully diluted-shares outstanding.

For the year, Revenue is now projected to be $1,230 million to $1,270 million, reflecting growth of 13% to 17%, Net income is projected to be $68.4 million to $75.4 million, or $0.68 to $0.75 per diluted share, on the basis of approximately 100 million assumed weighted-average fully diluted-shares outstanding.